Wednesday
30Sep2009
Wednesday, September 30, 2009 at 10:14AM Press Releases
Wednesday, September 30, 2009 at 10:14AM Tuesday
03Mar2009
Tuesday, March 3, 2009 at 04:05PM Research on StressEraser as Adjunct Depression Treatment Presented at Psychosomatic Medicine Conference
Examines treatment of patients with major depressive disorder who present with low HRV
Monday
08Sep2008
Monday, September 8, 2008 at 08:05AM StressEraser Retail Price Lowered to $179
Savings in manufacturing costs will be passed along to stressed-out consumers
Monday
21Jul2008
Monday, July 21, 2008 at 08:05AM StressEraser Selected for Prestigious ESPY 2008 VIP Gift Bag
The ESPY gift bag celebrates excellence in superior products
Monday
16Jun2008
Monday, June 16, 2008 at 08:05AM Study Examines the StressEraser's Effectiveness as an Adjunct Treatment for Cognitive Behavioral Therapies
New research published in current edition of the journal "Applied Psychophysiology and Biofeedback"
Monday
02Jun2008
Monday, June 2, 2008 at 08:05AM New Study Evaluates StressEraser Accuracy
Research published in the journal "Applied Psychophysiology and Biofeedback" determines the accuracy of the StressEraser relative to hospital-grade ECG equipment
Tuesday
27May2008
Tuesday, May 27, 2008 at 08:05AM The R2C Group Announces New Campaign for Helicor's StressEraser
TV commercials showcase revolutionary personal biofeedback device
Wednesday
14May2008
Wednesday, May 14, 2008 at 08:05AM StressEraser Subject of AAPB Presentations
Three StressEraser-based research papers are featured at the 38th annual conference of the Association for Applied Psychophysiology and Biofeedback (AAPB) in Daytona Beach
Thursday
08May2008
Thursday, May 8, 2008 at 01:05PM StressEraser Featured on "The View"
200 audience members receive the portable biofeedback device; “We should all be using this; it’s a great gift for Mother’s Day” – Elisabeth Hasselbeck
Monday
05May2008
Monday, May 5, 2008 at 08:05AM StressEraser Clinical Research Overview Published in "Biofeedback" Journal
Scientific research paper, authored by Helicor's Director of Clinical Research, is accepted for publication